Zacks Investment Management’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-192,731	Closed	-$264K	–	710
2025 Q4	$264K	Sell	192,731 -333,401	-63%	-$440K	﹤0.01%	610
2025 Q3	$652K	Buy	526,132 +13,831	+3%	+$16.5K	0.01%	452
2025 Q2	$579K	Sell	512,301 -6,540	-1%	-$8.69K	0.01%	458
2025 Q1	$758K	Buy	518,841 +37,967	+8%	+$71.6K	0.01%	430
2024 Q4	$1.02M	Sell	480,874 -35,727	-7%	-$88.1K	0.01%	417
2024 Q3	$1.45M	Buy	+516,601	New	+$1.38M	0.01%	376
2024 Q2	–	Sell	-459,800	Closed	-$2.06M	–	622
2024 Q1	$2.06M	Buy	459,800 +67,357	+17%	+$281K	0.02%	307
2023 Q4	$1.26M	Buy	+392,443	New	+$1.11M	0.02%	353